EverSource Wealth Advisors, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1710537 BIRMINGHAM, AL

Position in ARWR

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$56,240

-$6,707 QoQ

Shares Held

690

-31.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#407

of 497 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EverSource Wealth Advisors, LLC holds $15,234,841 across 258 Biotechnology names. ARWR ranks #37 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	110,689	$6,036,977
2	INCY	Incyte Corp	9,004	$1,020,689
3	RPRX	Royalty Pharma plc	13,228	$741,689
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,357	$674,058
5	REGN	Regeneron Pharmaceuticals, Inc.	912	$568,663
6	BEAM	Beam Therapeutics Inc.	16,556	$568,200
7	EXEL	Exelixis, Inc.	8,321	$452,739
8	HALO	Halozyme Therapeutics, Inc.	4,146	$324,502

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,240	690	-31.3%	Shares	Sole	2026-07-24
2026-03-31	$62,947	1,004	+6.7%	Shares	Sole	2026-05-18
2025-12-31	$62,471	941	-7.5%	Shares	Sole	2026-02-06
2025-09-30	$35,075	1,017	+1.5%	Shares	Sole	2025-11-10
2025-06-30	$15,830	1,002	+305.7%	Shares	Sole	2025-08-13
2025-03-31	$3,146	247	+109.3%	Shares	Sole	2025-05-13
2024-12-31	$2,218	118	+4.4%	Shares	Sole	2025-02-10
2024-09-30	$2,188	113	0.0%	Shares	Sole	2024-11-08
2024-06-30	$2,936	113	+16.5%	Shares	Sole	2024-08-13
2024-03-31	$2,773	97	-24.8%	Shares	Sole	2024-06-11
2023-12-31	$3,947	129	+24.0%	Shares	Sole	2024-02-09
2023-09-30	$2,793	104	+103.9%	Shares	Sole	2023-11-03
2023-06-30	$1,818	51	-47.4%	Shares	Sole	2023-08-04
2022-03-31	$4,461	97	0.0%	Shares	Sole	2022-05-25
2021-12-31	$6,431	97	—	Shares	Sole	2022-02-17
No filing history on record for this holder in this stock.